BioInnovation Summit

2022 BioInnovation Summit Postponement Notice

Dear Speakers, Invited Guests, Exhibitors and Sponsors,

In order to conform to the latest pandemic control policies in Hangzhou, the committee of 2022 BioInnovation Summit decides to postpone the Summit from December 3-4 to the spring of 2023. The new conference date will be announced in our official Wechat account and website once it's confirmed.

We hereby sincerely apologize for any inconvenience caused. As the Summit organizer, we would continue our efforts and try our best to deliver our after-postponement service. Thanks for your trust and understanding.

See you next year in Hangzhou.

The Committee of 2022 BioInnovation Summit

November 29 2022

Speakers

Guo-Liang Yu

Chairman and CEO of Apollomics

Yingfei Wei

Chairperson of BioInnovation Summit, Chairwoman of BioInnovation Institute.

Bruce Beutler

Director of Center for the Genetics of Host Defense, UT Southwestern, 2011 Nobel Laureate in Physiology or Medicine

Hank Wuh

Surgeon, Inventor and Investor, Trustee of the University of Hawaii Foundation

Lin Xu

Chairman and Partner of China-U.S. Green Fund

Weili Hong

Visiting Professor at School of Economics of Fudan University

Tianjin Xu

Professor at School of Archaeology and Museology of Peking University, Director of Liangzhu Museum (Liangzhu Institute)

Kejian Huang

Founder of SinoType, Chairman and General Manager of Beijing SinoType Technology, Chief Multimedia Planner of Beijing Olympic Bid Committee Presentation Report

Yingxian Xiao

Dean of BioInnovation Institute

Yi-Wei Tang

Chief Medical Officer of Danaher Dx Platform/Cepheid China, Fellow of American Academy of Microbiology

Yao-Wei Huang

Professor in Department of Veterinary Medicine of Zhejiang University

Shibo Jiang

Director of Institute of Medical Microbiology in Fudan University, Fellow of American Academy of Microbiology

Jianwei Wang

Vice President of Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS/PUMC)

Ning Li

CEO of Shanghai Junshi Biosciences

Shoubai Chao

COO of CanSinoBIO

Patrick Y. Lu

Chairman of the Board, Executive Director, President & CEO

Yuling Li

Co-founder and CEO of Innoforce Pharmaceuticals

Jin Liang

Managing Director of CICC

Peizhuo Zhang

Chairman of Suzhou GenePharma

Long-Cheng Li

Founder, Chairman and CEO of Ractigen Therapeutics

Jia Fei

Professor/Doctoral Supervisor of School of Basic Medicine in Jinan University, Director of Guangdong Engineering Research Center for Small RNA Drug Development

Yu Wu

Partner & Patent Attorney of JunHe

Yun Yang

CTO of Shanghai Circode Biomed

Robert J. Lee

Chief Scientific Officer of Zhejiang Haichang Biotech Co., Ltd.

Dong Shen

Founder and CEO of RNAimmune

Zihui Fang

Senior Scientist of Center for Excellence of Innoforce Pharmaceuticals

Yuwen Liu

Founding Partner of BOHE Angel Fund

Lu Gao

CEO of Therorna Inc.

Dajie Tang

Chairman of Triwise Capital

Guoping Zhao

Member of Chinese Academy of Sciences

Daniel Ramon Vidal

Member of Royal Academy of Engineering of Spain

Chenli Liu

Vice President of Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

Lixin Zhang

Professor and Director of State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology

Enwei Xie

Partner of Transfar Innovation Polis Fund

Xibin Zhou

Co-founder, Chairman and General Manager of Synceres Biosciences

Baishan Fang

Director of Xiamen City Key Laboratory of Synthetic Biotechnology

Yiming Li

Professor at Southern University of Science and Technology, Co-founder and Chief Scientific Officer of Shengrui Biotech

Hui Zhu

Founder of NEWGEN BIO

Ran Chao

Co-founder and CEO of LifeFoundry

Ben Zhao

Founder and President of Zhejiang Haichang Biotech Co., Ltd.

Gang Chen

CSO of R&G PharmaStudies

Juhong Liu

CEO of GlobalSubmissions Consulting

Hongliu Ding

VP of Pulmongene

Shen Xiao

Chief Strategy Officer of 3D Medicines

Yaning Wang

CEO of Createrna Science and Technology

Shichun Zhang

BD Director of Novotech Shanghai

Ruyi He

Chief Medical Officer of RemeGen, Chief Scientist of SDIC Fund Management CO., LTD

Xiao Xiao

Chairman and founder of Belief Biomed

Richard Wang

CEO and Founder of Neukio Biotherapeutics

Lin Yang

CEO and Founder of PersonGen

Claire Zhang

CTO and Co-founder of Innostellar Biotherapeutics

Grace Zhou

CEO and Chairman of ImmVira

Tina Liu

Senior Associate of AllBright Law Offices

Al Lin

CEO of Innoland Biosciences (USA/China)

Fred Mao

Partner and Managing Director of Frost & Sullivan

Min Zhu

Senior VP of CDMO Operations of Innoforce Pharmaceuticals

Ying Yang

Founder and General Manager of Lab-Direct

Guang Gao

Senior Technical Officer at PATH China Office, Former FDA Senior Reviewer

Weihua Song

VP of Innoland Biosciences

Qiming Wang

Director of Products and Services of The Jackson Laboratory China

Jinsong Guo

Founder of DrugTimes, Co-Chairman and Secretary General of China Alliance for New Drug Development for Liver Diseases.

Long Zhang

Co-founder and President of MindRank AI in China

Fengfeng Xu

Executive Vice President of Abogenbio

Kelvin Shao

Vice General Manager of Kexing Biopharm Co., Ltd.

William Haseltine

professor
Professor, Central Academy of Fine Arts

Agenda

Keynote Program
Session A
Session B
Session C

Keynote Program

December 3rd, 2022, Saturday

Hangzhou International Expo Center

Time

Speech

Speaker

08:30 - 09:00

Opening Ceremony

Reserve

Keynote Program

09:00 - 09:40

Fireside Chat: Immortality, the Ultimate Challenge of Life Science

Bruce Beutler, Hank Wuh

Reserve

09:40 - 10:20

Strategy for Life Science and Biotech Companies under New Challenges

Guo-Liang Yu

Reserve

10:20 - 10:30

Stay Younger, Happier and Healthier: Announcing Dr. Guo-Liang Yu's 2nd Book

Guo-Liang Yu

Reserve

10:30 - 10:45

Coffee Break

Reserve

10:45 - 11:25

What Are New Drivers of Economic Growth in China?

Lin Xu

Reserve

11:25 - 12:00

The New Frontier of PE/VC Market in China with a Global Perspective

Weili Hong

Reserve

12:20 - 13:20

Lunch Program: Information Design of Chinese Ideograph in the Context of Meta Universe

Kejian Huang

Reserve

A Long and Complicated Relationship of Humans and Viruses: Past, Present and Future.

14:00 - 14:30

The Past and the Present of Clinical Virology

Yi-Wei Tang

Reserve

14:30 - 15:00

The Current and Future of COVID-19 Vaccines

Shibo Jiang

Reserve

15:00 - 15:30

Emerging Animal Coronaviruses: Interspecies Transmission and Control

Yao-Wei Huang

Reserve

15:30 - 15:45

Coffee Break

Reserve

15:45 - 16:10

Virus Mutation and Responses: Challenges and Prospects

Jianwei Wang

Reserve

16:10 - 16:35

Progress in Antiviral Drugs

Ning Li

Reserve

16:35 - 17:00

Progress in Antiviral Vaccines

Shoubai Chao

Reserve

17:00

Closing

Reserve

17:00 - 19:00

Light Dinner

Reserve

19:00 - 20:30

BioInnovation Talent Show

Reserve

Session A

December 4th, 2022, Sunday

Hangzhou International Expo Center

Time

Speech

Speaker

RNA Era: Technologies, Products, Pain Points, Future.

09:00 - 09:10

Opening Remarks

Reserve

09:10 - 09:50

Small RNA-based Drugs Development and Manufacturing: Opportunities and Challenges

Peizhuo Zhang

Reserve

09:50 - 10:30

Touching the Void – Delivering Oligonucleotides to the CNS

Long-Cheng Li

Reserve

10:30 - 10:45

Coffee Break

Reserve

10:45 - 11:20

Introduction of a New Track for Developing Small Nucleic Acid Drugs Targeting miRNA in Non-coding RNA

Jia Fei

Reserve

11:20 - 12:00

mRNA Technologies: Opportunities and Challenges

Dong Shen

Reserve

12:20 - 13:20

Lunch Program: Archaeology, a Window to Know the World

Tianjin Xu

Reserve

14:00 - 14:35

Patent Landscape Surrounding LNP and Recent Cases

Yu Wu

Reserve

14:35 - 15:10

Develop Technology Platform for Circular RNA Therapies

Yun Yang

Reserve

15:10 - 15:45

QTsomes for Delivery of Nucleic Acid Therapeutics

Robert J. Lee

Reserve

15:45 - 16:00

Coffee Break

Reserve

16:00 - 16:30

The End-to-End CMC Development Strategies and Challenges for mRNA Vaccines/Drugs

Zihui Fang

Reserve

16:30 - 17:30

Panel Discussion: Innovation in mRNA era - Dialogue with Investors

Yuling Li, Jin Liang, Dong Shen, Peizhuo Zhang, Yu...

Reserve

17:30

Closing of Session A

Reserve

Session B

December 4th, 2022, Sunday

Hangzhou International Expo Center

Time

Speech

Speaker

Biosynthesis

09:00 - 09:05

Opening Remarks

Dajie Tang

Reserve

09:05 - 09:30

Biosynthesis and Biotechnology: from Creation for Use to Industrial Transformation

Guoping Zhao

Reserve

09:30 - 10:00

Postbiotics: Microbiome Modulators for the Future

Daniel Ramon Vidal

Reserve

10:00 - 10:30

Biosynthesis Industry: Present and Future

Chenli Liu

Reserve

10:30 - 10:45

Coffee Break

Reserve

10:45 - 11:05

From Discovery to Intelligent Manufacturing of Microbial Drugs

Lixin Zhang

Reserve

11:05 - 12:00

Panel Discussion: The New Frontier of Synthetic Biology

Enwei Xie, Xibin Zhou, Baishan Fang, Yiming Li, Hu...

Reserve

12:20 - 13:20

Lunch Program: Archaeology, a Window to Know the World

Tianjin Xu

Reserve

Winning at the Starting Line for Chinese Pharmaceutical Companies' Oversea Strategy - in light of the FDA New Policy

14:00 - 14:05

Opening Remarks

Ben Zhao

Reserve

14:05 - 14:30

Key Considerations for the Global Clinical Trial(MRCT) Design and Case Studies

Gang Chen

Reserve

14:30 - 14:55

Management of CMC Changes from Clinical to Commercial-Transition from Quality to Quantity

Juhong Liu

Reserve

14:55 - 15:20

Discussion on the Clinical Trial Strategy of Domestic Innovative Pharmaceutical Companies Applying for Drug Registration both in China and the United States

Hongliu Ding

Reserve

15:20 - 15:45

Drug Development Strategies based on New Clinical Value Guidelines

Shen Xiao

Reserve

15:45 - 16:00

Coffee Break

Reserve

16:00 - 16:25

The Impact of FDA Optimus and Equity Projects on Global Oncology New Drug Development

Yaning Wang

Reserve

16:25 - 16:50

Simultaneous Global Development of China-originated Innovative Drugs

Shichun Zhang

Reserve

16:50 - 17:30

Panel Discussion: The Dawn of Chinese Innovative Biopharma Going Global

Ben Zhao, Ruyi He, Ning Li, Gang Chen, Shen Xiao,...

Reserve

17:30

Closing of Session B

Reserve

Session C

December 4th, 2022, Sunday

Hangzhou International Expo Center

Time

Speech

Speaker

Cell Gene Therapy: How to Do Better

09:00 - 09:05

Opening Remarks

Yuling Li

Reserve

09:05 - 09:30

Overview of Gene Therapy and its Development in China

Xiao Xiao

Reserve

09:30 - 10:00

Driving Next Generation Cell Therapy with iPSC-CAR-NK

Richard Wang

Reserve

10:00 - 10:30

The Latest Progress and Trend of Global CAR-T Cell Therapy for Solid Tumor

Lin Yang

Reserve

10:30 - 10:45

Coffee Break

Reserve

10:45 - 11:10

AAV-based Gene Therapies: CMC Development and IND Filing

Claire Zhang

Reserve

11:10 - 11:35

The Challenge and Breakthrough of Oncolytic Virus

Grace Zhou

Reserve

11:35 - 12:00

Cell and Gene Therapy Regulation and Pre-IPO Compliance Strategies in China and the United States

Tina Liu

Reserve

12:20 - 13:20

Lunch Program: Archaeology, a Window to Know the World

Tianjin Xu

Reserve

CXO (CRO, CDMO, CPO): “Silk Road Stations" for Innovative Drug R&D

14:00 - 14:15

Paradigm Shift in Biopharma Industry and the Prospect of CXOs: Building“Silk Road Stations" for Innovative Drug R&D

Al Lin

Reserve

14:15 - 14:45

Overview of CXO Business in China

Fred Mao

Reserve

14:45 - 15:05

Be a Proud CDMO that Enables New Drug Development

Min Zhu

Reserve

15:05 - 15:25

CPO (Contract Procurement Organization): SPM Supply Chain Builds a Highway" for Biomedical Industry

Ying Yang

Reserve

15:25 - 15:45

Global Regulation Road Map on ATMP Products Regulatory CMC- A Road Map for a Successful Journey

Guang Gao

Reserve

15:45 - 16:00

Coffee Break

Reserve

16:00 - 16:20

Innovative Mouse Models to Empower Drug Discovery

Qiming Wang

Reserve

16:20 - 16:40

Role of NHPs in Biopharma Research

Weihua Song

Reserve

16:40 - 17:30

Panel Discussion: Your Dream CXO Partner - a Sponsors’Perspective

Jinsong Guo, Al Lin, Long Zhang, Fengfeng Xu, Kelv...

Reserve

17:30

Closing of Session C

Reserve